T1	CHEM 60 69	LY3314814
#1	AnnotatorNotes T1	C5139740; lanabecestat; Organic Chemical 路 Pharmacologic Substance [https://www.drugbank.ca/drugs/DB14814]
T2	DISO 86 109	enfermedad de Alzheimer
#2	AnnotatorNotes T2	C0002395; Alzheimer's Disease; Disease or Syndrome
T3	PROC 149 196	Estudio aleatorizado, con doble enmascaramiento
T4	CHEM 249 256	AZD3293
T5	CHEM 238 247	LY3314814
#3	AnnotatorNotes T5	C5139740; lanabecestat; Organic Chemical 路 Pharmacologic Substance [https://www.drugbank.ca/drugs/DB14814]
T6	DISO 264 287	enfermedad de Alzheimer
#4	AnnotatorNotes T6	C0002395; Alzheimer's Disease; Disease or Syndrome
T7	DISO 379 402	Enfermedad de Alzheimer
#5	AnnotatorNotes T7	C0002395; Alzheimer's Disease; Disease or Syndrome
T8	DISO 446 469	Enfermedad de Alzheimer
#6	AnnotatorNotes T8	C0002395; Alzheimer's Disease; Disease or Syndrome
T9	DISO 488 512	deterioro cognitivo leve
T10	DISO 525 527	EA
#7	AnnotatorNotes T10	C0002395; Alzheimer's Disease; Disease or Syndrome
T11	DISO 533 535	EA
#8	AnnotatorNotes T11	C0002395; Alzheimer's Disease; Disease or Syndrome
T12	DISO 539 570	demencia leve de tipo Alzheimer
T13	DISO 529 532	DCL
T14	DISO 844 856	alteraciones
#9	AnnotatorNotes T14	C0221423; Illness (finding); Sign or Symptom
T15	CHEM 71 78	AZD3293
T16	Date 13 17	2016
T17	PHYS 498 507	cognitivo
#10	AnnotatorNotes T17	C0009240; Cognition; Mental Process
T18	PROC 623 633	reclutados
#11	AnnotatorNotes T18	C0242800; Patient Recruitment; Research Activity
T19	PROC 886 899	reclutamiento
#12	AnnotatorNotes T19	C0242800; Patient Recruitment; Research Activity
#13	AnnotatorNotes T3	C0206034; Clinical Trials, Randomized; Research Activity + C0013072; Double-Blind Method; Research Activity
#14	AnnotatorNotes T4	C4279730; AZD3293; Organic Chemical 路 Pharmacologic Substance 
#15	AnnotatorNotes T15	C4279730; AZD3293; Organic Chemical 路 Pharmacologic Substance 
#16	AnnotatorNotes T9	C1270972; Mild cognitive disorder; Mental or Behavioral Dysfunction 
#17	AnnotatorNotes T13	C1270972; Mild cognitive disorder; Mental or Behavioral Dysfunction
T20	LIVB 597 610	Participantes
#18	AnnotatorNotes T20	C4554048; Study Participant; Population Group
T21	LIVB 766 779	Participantes
#19	AnnotatorNotes T21	C4554048; Study Participant; Population Group
T22	Quantifier_or_Qualifier 113 126	fase temprana
#20	AnnotatorNotes T22	C2363430; Early stage; Temporal Concept
R1	Has_Quantifier_or_Qualifier Arg1:T2 Arg2:T22	
T23	Quantifier_or_Qualifier 291 304	fase temprana
#21	AnnotatorNotes T23	C2363430; Early stage; Temporal Concept
R2	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T23	
T24	Quantifier_or_Qualifier 406 419	fase temprana
#22	AnnotatorNotes T24	C2363430; Early stage; Temporal Concept
R3	Has_Quantifier_or_Qualifier Arg1:T7 Arg2:T24	
T25	Quantifier_or_Qualifier 473 486	fase temprana
#23	AnnotatorNotes T25	C2363430; Early stage; Temporal Concept
R4	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T25	
R6	Causes Arg1:T10 Arg2:T9	
R8	Causes Arg1:T11 Arg2:T9	
A1	Status T18 History_of
T26	Observation 664 705	cumplen con los criterios de elegibilidad
#24	AnnotatorNotes T26	C1302261; Patient eligible for clinical trial; Finding (?)
R9	Experiences Arg1:T20 Arg2:T18	
R10	Before Arg1:T18 Arg2:T26	
R11	Experiences Arg1:T21 Arg2:T14	
T27	Observation 784 794	participan
#25	AnnotatorNotes T27	C1278516; Patient participation status; Finding
R13	Before Arg1:T14 Arg2:T19	
R14	Before Arg1:T27 Arg2:T19	
T28	Quantifier_or_Qualifier 837 843	nuevas
#26	AnnotatorNotes T28	C0205314; New; Qualitative Concept
R15	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T28	
T29	Neg_cue 866 877	excluyentes
A2	Assertion T19 Negated
R16	Negation Arg1:T29 Arg2:T19	
R17	Causes Arg1:T8 Arg2:T9	
R5	Causes Arg1:T11 Arg2:T13	
R7	Causes Arg1:T10 Arg2:T13	
R18	Causes Arg1:T8 Arg2:T13	
R12	Experiences Arg1:T21 Arg2:T19	
A3	Experiencer T20 Patient
A4	Experiencer T21 Patient
